The Emergence of Lateral Flow Assays in Diagnostics
Authors: AZO Networks | Last updated: March 29, 2023
Overview
Before the COVID-19 pandemic, the pregnancy test was the most prominent rapid test on the market besides other tests to detect infectious diseases, such as HIV, flu, and malaria. The SARS-COV-2 virus has changed that tremendously. The rapid spread of the virus and its severe impact on human health created a need for a reliable and cheap tool to detect the virus at home.
The tool of choice was a well-established and well-known lateral flow assay (LFA) method. In this article with News-Medical, Hasret Altan-Martin, Product Manager for OEM Membranes at Sartorius, talks about what makes LFAs so successful, how to create a perfect LFA, and why nitrocellulose choice matters. Download the full interview now.
- Document type: Publication
- Page count: 4
- Read time: 5 minutes
Key Takeaways
- LFAs are cheap and provide rapid and reliable results that can be qualitative, semi-quantitative or quantitative.
- The nitrocellulose membrane is the matrix where all reagents flow along the strip, driven by capillary forces.
- Nitrocellulose membranes with increased protein binding and reduced capillary speed provide enhanced signal intensity.
- Sartorius is a globally recognized manufacturer of superior membranes for LFAs with a new technology for multiparameter lateral flow strip assays.
This Resource is Designed for:
- Healthcare
- Analytical Lab Assistants
- Engineers
- Lab Post Doc
- Lab Researchers
- Lab Technicians
- Medical Devices Manufacturers
Applications Supported:
- Lateral Flow Assays
- Diagnostics
- Rapid testing
- Membrane manufacturing
- Protein binding
- Biotherapeutics